Biotechnology
The Biotechnology industry has a total of 587 stocks, with a combined market cap of $1.09 trillion and total revenue of $110 billion.
Market Cap
1.09T
Revenue
110B
Profits
-41.27B
PE Ratio
n/a
Profit Margin
-37.51%
Dividend Yield
0.04%
587 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 113.41B | 1.15% | 1,530,039 | 12.22B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 64.65B | 1.07% | 975,365 | 14.92B |
| 3 | ARGX | argenx SE | 55.01B | 5.82% | 795,682 | 4.74B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 40.46B | -0.19% | 1,004,444 | 4.29B |
| 5 | RPRX | Royalty Pharma plc | 32.17B | 1.54% | 6,027,381 | 2.44B |
| 6 | RVMD | Revolution Medicines, Inc. | 31.73B | -4.15% | 2,140,219 | - |
| 7 | ONC | BeOne Medicines AG | 30.03B | -3.51% | 325,946 | 5.70B |
| 8 | BNTX | BioNTech SE | 22.27B | -1.69% | 704,170 | 3.23B |
| 9 | ROIV | Roivant Sciences Ltd. | 20.56B | -3.22% | 4,643,231 | 8.26M |
| 10 | INCY | Incyte Corporation | 20.45B | 1.13% | 2,641,263 | 5.36B |
| 11 | INSM | Insmed Incorporated | 20.42B | -10.20% | 7,956,252 | 819.56M |
| 12 | MRNA | Moderna, Inc. | 18.82B | -8.04% | 6,079,563 | 2.23B |
| 13 | GMAB | Genmab A/S | 15.12B | 1.70% | 2,085,794 | 3.90B |
| 14 | JAZZ | Jazz Pharmaceuticals plc | 14.97B | -0.62% | 677,984 | 4.44B |
| 15 | EXEL | Exelixis, Inc. | 13.25B | 0.40% | 2,161,807 | 2.38B |
| 16 | BBIO | BridgeBio Pharma, Inc. | 13.24B | 0.42% | 2,589,974 | 579.96M |
| 17 | ASND | Ascendis Pharma A/S | 13.07B | -3.83% | 592,713 | 998.25M |
| 18 | IONS | Ionis Pharmaceuticals, Inc. | 12.31B | -0.87% | 1,981,992 | 1.06B |
| 19 | AXSM | Axsome Therapeutics, Inc. | 11.96B | 0.36% | 1,117,553 | 708.24M |
| 20 | SMMT | Summit Therapeutics Inc. | 11.46B | -0.47% | 5,880,217 | - |
| 21 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.23B | -1.19% | 187,088 | 1.13B |
| 22 | BMRN | BioMarin Pharmaceutical Inc. | 10.97B | 0.53% | 2,232,610 | 3.24B |
| 23 | ARWR | Arrowhead Pharmaceuticals, Inc. | 10.30B | -2.75% | 1,227,702 | 622.01M |
| 24 | CYTK | Cytokinetics, Incorporated | 9.70B | -1.12% | 1,614,067 | 105.82M |
| 25 | KRYS | Krystal Biotech, Inc. | 8.87B | -2.21% | 264,303 | 417.30M |
| 26 | HALO | Halozyme Therapeutics, Inc. | 8.48B | -0.10% | 1,144,090 | 1.51B |
| 27 | TECH | Bio-Techne Corporation | 8.14B | -2.24% | 2,947,830 | 1.21B |
| 28 | ABVX | ABIVAX Société Anonyme | 8.08B | -3.24% | 2,625,137 | 5.67M |
| 29 | CORT | Corcept Therapeutics Incorporated | 7.80B | -3.03% | 774,655 | 769.10M |
| 30 | IBRX | ImmunityBio, Inc. | 7.25B | -5.08% | 12,774,062 | 140.98M |
| 31 | NUVL | Nuvalent, Inc. | 7.18B | -3.27% | 715,982 | - |
| 32 | PRAX | Praxis Precision Medicines, Inc. | 7.08B | -4.06% | 501,024 | 7.46M |
| 33 | PCVX | Vaxcyte, Inc. | 6.84B | -2.87% | 1,106,310 | - |
| 34 | APGE | Apogee Therapeutics, Inc. | 6.51B | -4.38% | 1,308,160 | - |
| 35 | SYRE | Spyre Therapeutics, Inc. | 6.40B | -6.15% | 1,479,790 | - |
| 36 | IMVT | Immunovant, Inc. | 6.39B | -4.78% | 872,045 | - |
| 37 | PTGX | Protagonist Therapeutics, Inc. | 6.26B | -5.26% | 887,387 | 74.06M |
| 38 | CNTA | Centessa Pharmaceuticals plc | 6.13B | -0.45% | 1,702,171 | 15.00M |
| 39 | KYMR | Kymera Therapeutics, Inc. | 6.10B | -0.64% | 639,318 | 51.48M |
| 40 | LEGN | Legend Biotech Corporation | 6.06B | -4.62% | 2,484,726 | 1.14B |
| 41 | RYTM | Rhythm Pharmaceuticals, Inc. | 5.92B | -1.38% | 417,777 | 217.17M |
| 42 | PTCT | PTC Therapeutics, Inc. | 5.89B | 0.47% | 937,025 | 827.11M |
| 43 | MIRM | Mirum Pharmaceuticals, Inc. | 5.70B | 1.07% | 585,272 | 569.61M |
| 44 | TGTX | TG Therapeutics, Inc. | 5.69B | -0.99% | 1,434,076 | 700.35M |
| 45 | BLTE | Belite Bio, Inc | 5.64B | -0.77% | 333,834 | - |
| 46 | SRRK | Scholar Rock Holding Corporation | 5.31B | -2.27% | 1,153,268 | - |
| 47 | COGT | Cogent Biosciences, Inc. | 5.30B | -5.40% | 1,795,094 | - |
| 48 | XENE | Xenon Pharmaceuticals Inc. | 5.00B | -2.38% | 1,686,197 | 7.50M |
| 49 | CRSP | CRISPR Therapeutics AG | 5.00B | -8.97% | 2,296,563 | 4.10M |
| 50 | LGND | Ligand Pharmaceuticals Incorporated | 4.75B | 0.46% | 174,942 | 274.48M |
| 51 | CGON | CG Oncology, Inc. | 4.74B | -4.23% | 951,497 | 5.07M |
| 52 | CAI | Caris Life Sciences, Inc. | 4.66B | -4.57% | 2,737,711 | 907.29M |
| 53 | DNTH | Dianthus Therapeutics, Inc. | 4.40B | -4.30% | 835,881 | 1.34M |
| 54 | CELC | Celcuity Inc. | 4.31B | -4.53% | 1,687,134 | - |
| 55 | TVTX | Travere Therapeutics, Inc. | 4.26B | -0.80% | 2,892,431 | 536.20M |
| 56 | MANE | Veradermics, Incorporated | 3.83B | -9.42% | 497,670 | - |
| 57 | EWTX | Edgewise Therapeutics, Inc. | 3.83B | -4.41% | 2,961,860 | - |
| 58 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.83B | -0.06% | 1,533,608 | 596.96M |
| 59 | ERAS | Erasca, Inc. | 3.72B | -9.80% | 6,143,121 | - |
| 60 | ACAD | ACADIA Pharmaceuticals Inc. | 3.69B | -0.74% | 807,264 | 1.10B |
| 61 | NAMS | NewAmsterdam Pharma Company N.V. | 3.68B | -3.52% | 1,108,372 | 22.57M |
| 62 | ORKA | Oruka Therapeutics, Inc. | 3.63B | -3.44% | 1,301,594 | - |
| 63 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.47B | -4.97% | 863,203 | 18.07M |
| 64 | VKTX | Viking Therapeutics, Inc. | 3.30B | -4.47% | 2,733,918 | - |
| 65 | TLX | Telix Pharmaceuticals Limited | 3.19B | -2.52% | 262,827 | 803.79M |
| 66 | DNLI | Denali Therapeutics Inc. | 3.10B | -3.08% | 2,190,125 | - |
| 67 | RLAY | Relay Therapeutics, Inc. | 2.95B | -7.02% | 6,071,411 | 10.68M |
| 68 | BEAM | Beam Therapeutics Inc. | 2.93B | -10.48% | 2,365,228 | 164.01M |
| 69 | TNGX | Tango Therapeutics, Inc. | 2.92B | -8.71% | 4,017,887 | 56.99M |
| 70 | RCUS | Arcus Biosciences, Inc. | 2.92B | -6.08% | 866,957 | 236.00M |
| 71 | DYN | Dyne Therapeutics, Inc. | 2.82B | -7.44% | 1,882,591 | - |
| 72 | GPCR | Structure Therapeutics Inc. | 2.67B | -3.79% | 515,293 | - |
| 73 | ARQT | Arcutis Biotherapeutics, Inc. | 2.66B | -3.28% | 1,209,409 | 415.62M |
| 74 | DFTX | Definium Therapeutics, Inc. | 2.57B | -4.23% | 4,182,132 | - |
| 75 | IRON | Disc Medicine, Inc. | 2.56B | -5.78% | 454,504 | - |
| 76 | TARS | Tarsus Pharmaceuticals, Inc. | 2.55B | -1.76% | 370,081 | 535.08M |
| 77 | KLRA | Kailera Therapeutics, Inc. | 2.51B | -7.72% | 450,718 | - |
| 78 | IDYA | IDEAYA Biosciences, Inc. | 2.49B | -3.18% | 710,868 | 225.27M |
| 79 | ALMS | Alumis Inc. | 2.43B | -6.52% | 1,436,419 | 8.40M |
| 80 | VERA | Vera Therapeutics, Inc. | 2.32B | -3.27% | 1,515,652 | - |
| 81 | CLDX | Celldex Therapeutics, Inc. | 2.25B | -4.38% | 1,273,287 | 865.00K |
| 82 | PHVS | Pharvaris N.V. | 2.17B | -1.71% | 775,064 | - |
| 83 | RARE | Ultragenyx Pharmaceutical Inc. | 2.15B | -6.01% | 1,117,021 | 670.00M |
| 84 | ELVN | Enliven Therapeutics, Inc. | 2.11B | -2.20% | 1,076,325 | - |
| 85 | IMNM | Immunome, Inc. | 2.10B | -5.59% | 895,711 | 4.02M |
| 86 | AUPH | Aurinia Pharmaceuticals Inc. | 2.04B | -3.24% | 1,275,206 | 298.30M |
| 87 | MLYS | Mineralys Therapeutics, Inc. | 1.95B | -5.43% | 4,182,839 | - |
| 88 | KOD | Kodiak Sciences Inc. | 1.94B | -9.10% | 1,450,411 | - |
| 89 | NKTR | Nektar Therapeutics | 1.94B | -3.36% | 1,033,573 | 55.63M |
| 90 | TRVI | Trevi Therapeutics, Inc. | 1.89B | -4.31% | 729,270 | - |
| 91 | NTLA | Intellia Therapeutics, Inc. | 1.89B | -8.20% | 7,007,367 | 66.09M |
| 92 | IOVA | Iovance Biotherapeutics, Inc. | 1.89B | -3.42% | 17,999,132 | 285.61M |
| 93 | MESO | Mesoblast Limited | 1.88B | -6.56% | 260,169 | 65.38M |
| 94 | STOK | Stoke Therapeutics, Inc. | 1.87B | -0.37% | 569,515 | 32.08M |
| 95 | ZLAB | Zai Lab Limited | 1.87B | -4.15% | 1,694,977 | 453.28M |
| 96 | HRMY | Harmony Biosciences Holdings, Inc. | 1.86B | -2.31% | 461,366 | 899.11M |
| 97 | LKFT | Lakefront Biotherapeutics NV | 1.86B | -0.46% | 138,581 | 1.20B |
| 98 | VCEL | Vericel Corporation | 1.85B | 1.71% | 558,316 | 292.09M |
| 99 | ADMA | ADMA Biologics, Inc. | 1.85B | -0.13% | 2,496,058 | 509.86M |
| 100 | NBTX | Nanobiotix S.A. | 1.81B | -3.96% | 49,645 | 38.27M |
| 101 | OCUL | Ocular Therapeutix, Inc. | 1.81B | -6.25% | 1,348,699 | 52.04M |
| 102 | RXRX | Recursion Pharmaceuticals, Inc. | 1.76B | -12.76% | 26,914,950 | 66.41M |
| 103 | ZYME | Zymeworks Inc. | 1.76B | -4.22% | 464,815 | 81.26M |
| 104 | VRDN | Viridian Therapeutics, Inc. | 1.74B | -4.77% | 1,783,375 | 70.92M |
| 105 | RAPP | Rapport Therapeutics, Inc. | 1.73B | -3.71% | 181,278 | 20.00M |
| 106 | ABCL | AbCellera Biologics Inc. | 1.72B | -11.77% | 8,245,325 | 79.21M |
| 107 | AGIO | Agios Pharmaceuticals, Inc. | 1.68B | -1.74% | 561,318 | 66.05M |
| 108 | NUVB | Nuvation Bio Inc. | 1.68B | -6.77% | 3,475,999 | 143.05M |
| 109 | QURE | uniQure N.V. | 1.67B | -5.50% | 1,450,593 | 18.09M |
| 110 | SRPT | Sarepta Therapeutics, Inc. | 1.66B | -5.46% | 2,062,959 | 2.18B |
| 111 | INVA | Innoviva, Inc. | 1.66B | 1.62% | 845,393 | 420.69M |
| 112 | GENB | Generate Biomedicines, Inc. | 1.65B | -12.45% | 1,619,619 | 30.30M |
| 113 | AAPG | Ascentage Pharma Group International | 1.64B | -5.91% | 13,576 | 82.08M |
| 114 | BHVN | Biohaven Ltd. | 1.63B | -5.26% | 2,034,753 | - |
| 115 | SION | Sionna Therapeutics, Inc. | 1.60B | -6.38% | 461,279 | - |
| 116 | TYRA | Tyra Biosciences, Inc. | 1.58B | -1.99% | 1,454,893 | - |
| 117 | TSHA | Taysha Gene Therapies, Inc. | 1.58B | -6.62% | 1,360,862 | 7.47M |
| 118 | NVAX | Novavax, Inc. | 1.56B | -6.87% | 4,170,355 | 596.34M |
| 119 | PVLA | Palvella Therapeutics, Inc. | 1.56B | -5.36% | 374,164 | - |
| 120 | CAPR | Capricor Therapeutics, Inc. | 1.55B | -4.44% | 576,079 | 11.13M |
| 121 | SNDX | Syndax Pharmaceuticals, Inc. | 1.54B | -3.77% | 2,702,241 | 217.17M |
| 122 | SLS | SELLAS Life Sciences Group, Inc. | 1.53B | -8.96% | 6,396,087 | - |
| 123 | FTRE | Fortrea Holdings Inc. | 1.52B | -6.78% | 1,033,167 | 2.71B |
| 124 | NRIX | Nurix Therapeutics, Inc. | 1.51B | -4.19% | 1,367,589 | 71.78M |
| 125 | GHRS | GH Research PLC | 1.47B | -7.83% | 316,109 | - |
| 126 | ANAB | AnaptysBio, Inc. | 1.47B | -2.52% | 452,140 | 232.39M |
| 127 | VIR | Vir Biotechnology, Inc. | 1.46B | -5.46% | 1,127,980 | 65.50M |
| 128 | ATAI | AtaiBeckley Inc. | 1.45B | -12.22% | 9,234,706 | 3.49M |
| 129 | MBX | MBX Biosciences, Inc. | 1.44B | -2.04% | 580,356 | - |
| 130 | IMCR | Immunocore Holdings plc | 1.44B | -1.63% | 282,085 | 412.81M |
| 131 | KALV | KalVista Pharmaceuticals, Inc. | 1.43B | - | 1,715,088 | 114.48M |
| 132 | AVBP | ArriVent BioPharma, Inc. | 1.41B | -8.28% | 634,862 | - |
| 133 | SEPN | Septerna, Inc. | 1.40B | -0.70% | 211,653 | 72.26M |
| 134 | GLUE | Monte Rosa Therapeutics, Inc. | 1.38B | -5.70% | 949,049 | 42.95M |
| 135 | ARDX | Ardelyx, Inc. | 1.37B | 2.96% | 4,589,181 | 427.68M |
| 136 | MAZE | Maze Therapeutics, Inc. | 1.34B | -4.45% | 445,614 | 20.00M |
| 137 | MLTX | MoonLake Immunotherapeutics | 1.32B | -4.38% | 538,485 | - |
| 138 | BCAX | Bicara Therapeutics Inc. | 1.31B | -2.01% | 356,197 | - |
| 139 | IMTX | Immatics N.V. | 1.31B | -3.83% | 1,129,261 | 43.00M |
| 140 | URGN | UroGen Pharma Ltd. | 1.31B | -2.72% | 704,098 | 140.49M |
| 141 | DMRA | Damora Therapeutics, Inc. | 1.30B | -5.56% | 523,534 | - |
| 142 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.30B | 0.60% | 2,084,415 | 204.73M |
| 143 | SVRA | Savara Inc. | 1.29B | -3.96% | 1,204,873 | - |
| 144 | INBX | Inhibrx Biosciences, Inc. | 1.28B | -4.65% | 417,428 | 1.30M |
| 145 | PGEN | Precigen, Inc. | 1.28B | -7.25% | 5,330,544 | 31.60M |
| 146 | MPLT | MapLight Therapeutics, Inc. | 1.27B | -6.94% | 478,181 | - |
| 147 | AVLN | Avalyn Pharma Inc. | 1.13B | 0.26% | 327,006 | - |
| 148 | COAG | Hemab Therapeutics Holdings, Inc. | 1.12B | -0.57% | 184,205 | - |
| 149 | ZBIO | Zenas BioPharma, Inc. | 1.10B | -4.95% | 494,075 | 10.00M |
| 150 | WVE | Wave Life Sciences Ltd. | 1.10B | -5.91% | 3,542,514 | 71.80M |
| 151 | MNKD | MannKind Corporation | 1.05B | -3.41% | 3,241,599 | 360.78M |
| 152 | AKTS | Aktis Oncology, Inc. | 1.04B | -5.13% | 138,618 | 8.28M |
| 153 | ABSI | Absci Corporation | 997.79M | -12.81% | 4,834,144 | 1.84M |
| 154 | EYPT | EyePoint, Inc. | 987.65M | -3.92% | 925,233 | 7.61M |
| 155 | DBVT | DBV Technologies S.A. | 974.54M | -5.52% | 273,476 | 5.74M |
| 156 | CRVS | Corvus Pharmaceuticals, Inc. | 935.09M | -5.12% | 1,182,124 | - |
| 157 | PHAR | Pharming Group N.V. | 911.36M | 0.57% | 10,670 | 369.49M |
| 158 | OLMA | Olema Pharmaceuticals, Inc. | 900.55M | -3.46% | 2,518,653 | - |
| 159 | XNCR | Xencor, Inc. | 872.65M | -2.00% | 862,474 | 97.36M |
| 160 | SPTX | Seaport Therapeutics, Inc. | 871.78M | -8.05% | 170,721 | - |
| 161 | ANNX | Annexon, Inc. | 866.73M | -2.94% | 1,762,568 | - |
| 162 | SPRY | ARS Pharmaceuticals, Inc. | 850.04M | -5.62% | 1,288,222 | 98.99M |
| 163 | LXRX | Lexicon Pharmaceuticals, Inc. | 848.42M | 0.53% | 1,761,548 | 69.64M |
| 164 | DRTS | Alpha Tau Medical Ltd. | 843.15M | -9.14% | 1,354,083 | - |
| 165 | TBPH | Theravance Biopharma, Inc. | 839.80M | -0.49% | 242,785 | 109.78M |
| 166 | ABUS | Arbutus Biopharma Corporation | 839.54M | -2.30% | 1,124,740 | 191.45M |
| 167 | IVA | Inventiva S.A. | 839.46M | -4.73% | 1,083,244 | 7.94M |
| 168 | JBIO | Jade Biosciences, Inc. | 836.16M | -4.51% | 2,600,892 | - |
| 169 | MGTX | MeiraGTx Holdings plc | 833.49M | -5.96% | 693,693 | 79.76M |
| 170 | CGEM | Cullinan Therapeutics, Inc. | 830.30M | -6.38% | 656,305 | - |
| 171 | LBRX | LB Pharmaceuticals Inc | 820.15M | -1.04% | 156,848 | - |
| 172 | JANX | Janux Therapeutics, Inc. | 814.14M | -2.98% | 490,576 | 13.73M |
| 173 | PHAT | Phathom Pharmaceuticals, Inc. | 804.63M | 2.74% | 1,157,039 | 204.89M |
| 174 | REPL | Replimune Group, Inc. | 781.96M | -4.05% | 4,607,289 | - |
| 175 | ORIC | ORIC Pharmaceuticals, Inc. | 776.38M | -6.48% | 1,036,972 | - |
| 176 | KURA | Kura Oncology, Inc. | 775.89M | -0.34% | 3,225,404 | 71.64M |
| 177 | ODTX | Odyssey Therapeutics, Inc. | 775.07M | -3.35% | 389,821 | 2.98M |
| 178 | GERN | Geron Corporation | 750.58M | -3.31% | 9,599,233 | 196.12M |
| 179 | SANA | Sana Biotechnology, Inc. | 745.82M | -9.46% | 4,682,250 | - |
| 180 | AURA | Aura Biosciences, Inc. | 731.29M | -2.50% | 347,124 | - |
| 181 | DRUG | Bright Minds Biosciences Inc. | 724.67M | -7.38% | 712,345 | - |
| 182 | EVMN | Evommune, Inc. | 717.49M | -3.72% | 391,307 | 10.00M |
| 183 | VOR | Vor Biopharma Inc. | 713.08M | -8.10% | 540,011 | - |
| 184 | OMER | Omeros Corporation | 708.55M | -4.49% | 1,543,654 | 9.89M |
| 185 | AVTX | Avalo Therapeutics, Inc. | 688.61M | -3.75% | 1,757,605 | 59.00K |
| 186 | OCS | Oculis Holding AG | 676.95M | -5.24% | 827,137 | 1.40M |
| 187 | DSGN | Design Therapeutics, Inc. | 665.17M | -1.02% | 697,230 | - |
| 188 | SLDB | Solid Biosciences Inc. | 659.61M | -7.46% | 701,693 | - |
| 189 | CRMD | CorMedix Inc. | 655.86M | -2.11% | 906,183 | 400.05M |
| 190 | CTMX | CytomX Therapeutics, Inc. | 653.11M | -5.66% | 3,419,595 | 35.54M |
| 191 | ALLO | Allogene Therapeutics, Inc. | 648.89M | -7.84% | 7,542,057 | 22.00K |
| 192 | ANRO | Alto Neuroscience, Inc. | 640.06M | -8.84% | 414,098 | - |
| 193 | TENX | Tenax Therapeutics, Inc. | 631.76M | -3.25% | 560,365 | - |
| 194 | SGP | SpyGlass Pharma, Inc. | 627.75M | -3.54% | 77,527 | - |
| 195 | ZVRA | Zevra Therapeutics, Inc. | 627.21M | -5.01% | 2,136,577 | 122.29M |
| 196 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 625.64M | -5.10% | 305,628 | - |
| 197 | RLMD | Relmada Therapeutics, Inc. | 624.10M | -5.71% | 1,255,394 | - |
| 198 | CADL | Candel Therapeutics, Inc. | 623.53M | -8.20% | 2,047,168 | - |
| 199 | ACRS | Aclaris Therapeutics, Inc. | 608.93M | -7.43% | 928,945 | 8.37M |
| 200 | CBIO | Crescent Biopharma, Inc. | 598.12M | -2.44% | 192,619 | 11.88M |
| 201 | TRAX | First Tracks Biotherapeutics, Inc. | 579.21M | -8.79% | 868,752 | - |
| 202 | GYRE | Gyre Therapeutics, Inc. | 574.73M | 1.62% | 137,879 | 117.05M |
| 203 | MDXG | MiMedx Group, Inc. | 557.06M | -1.06% | 1,156,680 | 389.42M |
| 204 | RIGL | Rigel Pharmaceuticals, Inc. | 553.77M | -1.06% | 498,314 | 299.77M |
| 205 | IMMX | Immix Biopharma, Inc. | 553.44M | -5.82% | 1,267,666 | - |
| 206 | PRME | Prime Medicine, Inc. | 552.69M | -11.82% | 4,258,238 | 4.03M |
| 207 | TECX | Tectonic Therapeutic, Inc. | 549.61M | -0.01% | 85,470 | - |
| 208 | PROK | ProKidney Corp. | 543.71M | -2.70% | 1,519,461 | 889.00K |
| 209 | DNA | Ginkgo Bioworks Holdings, Inc. | 536.97M | -9.17% | 1,383,151 | 151.40M |
| 210 | CABA | Cabaletta Bio, Inc. | 529.93M | -7.41% | 4,285,693 | - |
| 211 | XOMA | XOMA Royalty Corporation | 527.85M | -0.73% | 41,947 | 48.56M |
| 212 | ALT | Altimmune, Inc. | 527.02M | -7.19% | 2,866,739 | 36.00K |
| 213 | ACHV | Achieve Life Sciences, Inc. | 526.64M | -3.02% | 721,299 | - |
| 214 | VALN | Valneva SE | 513.32M | -3.35% | 36,900 | 180.25M |
| 215 | CLYM | Climb Bio, Inc. | 503.96M | -3.30% | 985,563 | - |
| 216 | AGMB | AgomAb Therapeutics NV | 488.54M | -16.57% | 97,772 | - |
| 217 | EIKN | Eikon Therapeutics, Inc. | 485.08M | -8.38% | 229,292 | - |
| 218 | ARVN | Arvinas, Inc. | 478.75M | -4.13% | 649,836 | 89.40M |
| 219 | PRTA | Prothena Corporation plc | 460.18M | -4.97% | 656,302 | 57.94M |
| 220 | ASMB | Assembly Biosciences, Inc. | 453.82M | -5.02% | 130,629 | 71.10M |
| 221 | KYTX | Kyverna Therapeutics, Inc. | 452.16M | -6.04% | 617,363 | - |
| 222 | FDMT | 4D Molecular Therapeutics, Inc. | 451.67M | -13.69% | 644,542 | 88.24M |
| 223 | OVID | Ovid Therapeutics Inc. | 447.94M | -3.23% | 1,410,873 | 7.12M |
| 224 | RZLT | Rezolute, Inc. | 443.98M | -5.76% | 1,998,598 | - |
| 225 | OCGN | Ocugen, Inc. | 433.31M | -6.57% | 5,020,083 | 4.47M |
| 226 | STRO | Sutro Biopharma, Inc. | 432.32M | -9.03% | 295,736 | 99.61M |
| 227 | CTNM | Contineum Therapeutics, Inc. | 429.38M | -6.93% | 285,368 | - |
| 228 | EPRX | Eupraxia Pharmaceuticals Inc. | 424.34M | -7.75% | 356,564 | - |
| 229 | CCCC | C4 Therapeutics, Inc. | 424.20M | -7.67% | 2,126,931 | 34.86M |
| 230 | NGNE | Neurogene Inc. | 418.59M | -3.60% | 67,356 | 925.00K |
| 231 | SGMT | Sagimet Biosciences Inc. | 417.44M | -4.25% | 608,041 | - |
| 232 | EDIT | Editas Medicine, Inc. | 415.88M | -9.36% | 2,293,452 | 38.69M |
| 233 | INDP | Indaptus Therapeutics, Inc. | 414.47M | -22.95% | 2,722,118 | - |
| 234 | ANL | Adlai Nortye Ltd. | 407.21M | -7.45% | 147,124 | 5.00M |
| 235 | AUTL | Autolus Therapeutics plc | 407.20M | -7.83% | 1,461,686 | 92.62M |
| 236 | FBRX | Forte Biosciences, Inc. | 403.92M | -0.96% | 408,707 | - |
| 237 | MNPR | Monopar Therapeutics Inc. | 400.45M | 0.29% | 193,321 | - |
| 238 | VTVT | vTv Therapeutics Inc. | 398.84M | -6.42% | 39,951 | 36.84M |
| 239 | CNXU | Conexeu Sciences Inc. | 385.23M | -4.72% | 35,515 | - |
| 240 | IPSC | Century Therapeutics, Inc. | 384.16M | -3.18% | 1,870,867 | 109.16M |
| 241 | UPB | Upstream Bio, Inc. | 383.66M | -5.11% | 592,708 | 3.32M |
| 242 | PRLD | Prelude Therapeutics Incorporated | 377.87M | -6.62% | 220,938 | 16.72M |
| 243 | CMPX | Compass Therapeutics, Inc. | 367.38M | -4.23% | 2,776,998 | 850.00K |
| 244 | VNDA | Vanda Pharmaceuticals Inc. | 362.62M | -3.52% | 713,106 | 217.78M |
| 245 | BNTC | Benitec Biopharma Inc. | 362.44M | -4.57% | 42,177 | - |
| 246 | XFOR | X4 Pharmaceuticals, Inc. | 361.24M | -4.49% | 445,228 | 9.01M |
| 247 | OABI | OmniAb, Inc. | 359.53M | -6.77% | 494,125 | 28.94M |
| 248 | PBYI | Puma Biotechnology, Inc. | 357.82M | 0.29% | 172,088 | 227.18M |
| 249 | STTK | Shattuck Labs, Inc. | 351.20M | -4.58% | 1,034,233 | 1.00M |
| 250 | LXEO | Lexeo Therapeutics, Inc. | 343.14M | -8.58% | 347,197 | - |
| 251 | AVIR | Atea Pharmaceuticals, Inc. | 340.12M | -3.85% | 217,601 | - |
| 252 | ARTV | Artiva Biotherapeutics, Inc. | 332.83M | -10.81% | 361,036 | 251.00K |
| 253 | LRMR | Larimar Therapeutics, Inc. | 330.89M | -3.65% | 1,239,604 | - |
| 254 | ENTA | Enanta Pharmaceuticals, Inc. | 328.00M | -4.01% | 135,055 | 69.21M |
| 255 | GLSI | Greenwich LifeSciences, Inc. | 326.59M | -6.00% | 172,821 | - |
| 256 | VSTM | Verastem, Inc. | 326.01M | -3.89% | 3,045,937 | 49.59M |
| 257 | ZURA | Zura Bio Limited | 322.59M | -7.36% | 4,956,993 | - |
| 258 | RGNX | REGENXBIO Inc. | 314.32M | -11.63% | 1,499,964 | 87.82M |
| 259 | ABEO | Abeona Therapeutics Inc. | 311.48M | -6.10% | 881,773 | 14.54M |
| 260 | DMAC | DiaMedica Therapeutics Inc. | 303.90M | -3.42% | 195,882 | - |
| 261 | NAUT | Nautilus Biotechnology, Inc. | 303.72M | -10.82% | 491,448 | - |
| 262 | IVVD | Invivyd, Inc. | 303.45M | -7.21% | 4,973,125 | 55.87M |
| 263 | FENC | Fennec Pharmaceuticals Inc. | 302.21M | -5.02% | 169,981 | 51.00M |
| 264 | RCKT | Rocket Pharmaceuticals, Inc. | 300.28M | -5.82% | 2,557,305 | - |
| 265 | HUMA | Humacyte, Inc. | 299.73M | -9.40% | 6,428,996 | 2.02M |
| 266 | NMRA | Neumora Therapeutics, Inc. | 297.78M | -6.86% | 864,572 | - |
| 267 | LCTX | Lineage Cell Therapeutics, Inc. | 296.66M | -1.65% | 980,604 | 14.78M |
| 268 | BCYC | Bicycle Therapeutics plc | 292.51M | -1.87% | 479,013 | 63.50M |
| 269 | SLN | Silence Therapeutics plc | 291.44M | -9.93% | 160,470 | 839.00K |
| 270 | PALI | Palisade Bio, Inc. | 291.32M | -9.84% | 4,238,021 | - |
| 271 | IRD | Opus Genetics, Inc. | 287.75M | -13.15% | 1,017,102 | 11.98M |
| 272 | LYEL | Lyell Immunopharma, Inc. | 279.31M | -8.28% | 96,677 | 31.00K |
| 273 | IKT | Inhibikase Therapeutics, Inc. | 277.79M | -1.81% | 578,348 | 1.00 |
| 274 | IMRX | Immuneering Corporation | 276.26M | -4.69% | 1,335,690 | - |
| 275 | NAGE | Niagen Bioscience, Inc. | 275.35M | -1.43% | 683,179 | 130.42M |
| 276 | ARMP | Armata Pharmaceuticals, Inc. | 275.21M | -2.47% | 36,758 | 5.20M |
| 277 | IFRX | InflaRx N.V. | 271.02M | -8.00% | 1,358,263 | 33.82K |
| 278 | ELDN | Eledon Pharmaceuticals, Inc. | 263.60M | -5.28% | 704,795 | - |
| 279 | ZNTL | Zentalis Pharmaceuticals, Inc. | 260.54M | -5.43% | 1,014,381 | 26.87M |
| 280 | SLGL | Sol-Gel Technologies Ltd. | 254.92M | 4.85% | 23,703 | 18.47M |
| 281 | NVCT | Nuvectis Pharma, Inc. | 253.05M | -1.34% | 74,371 | - |
| 282 | SRZN | Surrozen, Inc. | 251.02M | -11.32% | 97,000 | 7.49M |
| 283 | MGNX | MacroGenics, Inc. | 248.84M | -7.88% | 559,879 | 157.08M |
| 284 | FULC | Fulcrum Therapeutics, Inc. | 245.88M | 9.50% | 3,954,556 | 80.00M |
| 285 | ELTX | Elicio Therapeutics, Inc. | 242.46M | -5.38% | 114,874 | - |
| 286 | AVXL | Anavex Life Sciences Corp. | 238.17M | -8.87% | 942,439 | - |
| 287 | SABS | SAB Biotherapeutics, Inc. | 237.53M | -2.59% | 352,028 | 114.70K |
| 288 | TARA | Protara Therapeutics, Inc. | 233.81M | -5.67% | 442,478 | - |
| 289 | OBIO | Orchestra BioMed Holdings, Inc. | 232.94M | -2.51% | 138,771 | 32.72M |
| 290 | CDXS | Codexis, Inc. | 232.70M | -8.57% | 1,318,369 | 78.09M |
| 291 | NERV | Minerva Neurosciences, Inc. | 231.08M | 3.77% | 113,997 | - |
| 292 | FATE | Fate Therapeutics, Inc. | 230.79M | -10.41% | 3,782,656 | 6.32M |
| 293 | TRDA | Entrada Therapeutics, Inc. | 229.53M | -9.00% | 195,030 | 5.74M |
| 294 | CHRS | Coherus Oncology, Inc. | 223.66M | -7.94% | 857,267 | 46.88M |
| 295 | ACIU | AC Immune SA | 223.20M | -6.25% | 327,627 | 4.62M |
| 296 | QTTB | Q32 Bio Inc. | 222.30M | -6.36% | 761,775 | 53.74M |
| 297 | CLLS | Cellectis S.A. | 221.33M | -2.86% | 46,987 | 75.11M |
| 298 | LENZ | LENZ Therapeutics, Inc. | 219.79M | -2.64% | 430,353 | 20.99M |
| 299 | ADAG | Adagene Inc. | 219.36M | -7.26% | 295,329 | 7.67M |
| 300 | FHTX | Foghorn Therapeutics Inc. | 219.00M | -0.27% | 118,963 | 28.22M |
| 301 | CAMP | Camp4 Therapeutics Corporation | 213.42M | -4.42% | 68,957 | 3.93M |
| 302 | YDES | YD Bio Limited | 211.66M | -4.29% | 19,440 | 510.36K |
| 303 | HELP | Cybin Inc. | 207.65M | -6.32% | 781,537 | - |
| 304 | ARCT | Arcturus Therapeutics Holdings Inc. | 207.49M | -9.20% | 380,351 | 54.71M |
| 305 | ALXO | ALX Oncology Holdings Inc. | 207.22M | -1.28% | 858,190 | - |
| 306 | WHWK | Whitehawk Therapeutics, Inc. | 205.23M | -5.68% | 124,511 | 7.15M |
| 307 | KPTI | Karyopharm Therapeutics Inc. | 204.77M | 0.11% | 262,513 | 151.12M |
| 308 | KROS | Keros Therapeutics, Inc. | 203.86M | -4.36% | 163,505 | 33.18M |
| 309 | RNA | Atrium Therapeutics, Inc. | 201.85M | -4.07% | 209,387 | 36.68M |
| 310 | VYGR | Voyager Therapeutics, Inc. | 201.20M | -8.01% | 650,894 | 36.49M |
| 311 | CGEN | Compugen Ltd. | 198.63M | -5.41% | 232,879 | 72.66M |
| 312 | NGEN | NervGen Pharma Corp. | 197.54M | -7.46% | 1,032,197 | - |
| 313 | CRBU | Caribou Biosciences, Inc. | 190.43M | -7.02% | 1,617,567 | 11.20M |
| 314 | NBP | NovaBridge Biosciences | 190.24M | -8.61% | 598,655 | - |
| 315 | EQ | Equillium, Inc. | 185.89M | -7.26% | 1,143,757 | 4.39M |
| 316 | UNCY | Unicycive Therapeutics, Inc. | 184.76M | -6.86% | 1,198,681 | - |
| 317 | MDWD | MediWound Ltd. | 182.24M | -1.87% | 64,812 | 14.48M |
| 318 | ALEC | Alector, Inc. | 181.53M | -9.67% | 364,342 | 18.42M |
| 319 | NKTX | Nkarta, Inc. | 179.58M | -9.39% | 564,047 | - |
| 320 | TNXP | Tonix Pharmaceuticals Holding Corp. | 176.46M | -6.82% | 478,481 | 17.56M |
| 321 | IMUX | Immunic, Inc. | 173.95M | -11.50% | 254,053 | - |
| 322 | RNAC | Cartesian Therapeutics, Inc. | 171.59M | -10.84% | 278,785 | 1.78M |
| 323 | ENLV | Enlivex Ltd. | 171.14M | -10.18% | 307,699 | - |
| 324 | OKUR | OnKure Therapeutics, Inc. | 168.85M | -2.79% | 150,750 | - |
| 325 | DTIL | Precision BioSciences, Inc. | 167.71M | 1.40% | 253,322 | 45.07M |
| 326 | MIST | Milestone Pharmaceuticals Inc. | 167.34M | -4.65% | 2,128,642 | 1.78M |
| 327 | IPHA | Innate Pharma S.A. | 166.86M | -1.12% | 5,244 | 10.57M |
| 328 | SPRO | Spero Therapeutics, Inc. | 163.28M | -5.37% | 756,290 | 61.19M |
| 329 | CNTX | Context Therapeutics Inc. | 160.79M | -13.79% | 821,434 | - |
| 330 | TLSA | Tiziana Life Sciences Ltd | 160.34M | -2.36% | 81,572 | - |
| 331 | PLX | Protalix BioTherapeutics, Inc. | 160.34M | -1.00% | 545,868 | 76.38M |
| 332 | PRQR | ProQR Therapeutics N.V. | 158.04M | -1.96% | 449,718 | 15.73M |
| 333 | TNYA | Tenaya Therapeutics, Inc. | 158.00M | -5.70% | 4,433,015 | 225.00K |
| 334 | TTRX | Turn Therapeutics Inc. | 157.28M | -8.09% | 50,281 | - |
| 335 | ABOS | Acumen Pharmaceuticals, Inc. | 155.29M | -6.11% | 319,605 | - |
| 336 | KRRO | Korro Bio, Inc. | 154.61M | -4.11% | 187,667 | 3.84M |
| 337 | GALT | Galectin Therapeutics Inc. | 153.45M | -2.10% | 215,792 | - |
| 338 | ORMP | Oramed Pharmaceuticals Inc. | 151.84M | -2.62% | 99,733 | 2.00M |
| 339 | MENS | Jyong Biotech Ltd. | 149.95M | -3.81% | 58,901 | - |
| 340 | NRXP | NRx Pharmaceuticals, Inc. | 149.85M | 2.22% | 2,025,655 | 2.29M |
| 341 | MOLN | Molecular Partners AG | 141.62M | 4.32% | 2,080 | 856.30K |
| 342 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 140.07M | -5.62% | 327,151 | - |
| 343 | ANTX | AN2 Therapeutics, Inc. | 137.50M | -8.39% | 178,156 | - |
| 344 | CNTB | Connect Biopharma Holdings Limited | 136.63M | -5.65% | 277,498 | 233.00K |
| 345 | SPRB | Spruce Biosciences, Inc. | 136.28M | -5.15% | 33,824 | 697.00K |
| 346 | AGEN | Agenus Inc. | 134.17M | -4.86% | 434,606 | 123.87M |
| 347 | ADCT | ADC Therapeutics SA | 131.01M | -21.97% | 7,201,948 | 79.18M |
| 348 | CNTN | Canton Strategic Holdings, Inc. | 130.31M | -6.12% | 902,186 | - |
| 349 | GNLX | Genelux Corporation | 130.12M | -4.87% | 166,218 | 8.00K |
| 350 | ACOG | Alpha Cognition Inc. | 127.81M | -0.68% | 45,519 | 10.83M |
| 351 | KZIA | Kazia Therapeutics Limited | 125.58M | -3.60% | 186,490 | 1.27M |
| 352 | HURA | TuHURA Biosciences, Inc. | 125.14M | -10.27% | 1,068,465 | - |
| 353 | ALPS | Alps Group Inc | 118.14M | 1.39% | 10,860 | 3.74M |
| 354 | CGTX | Cognition Therapeutics, Inc. | 115.27M | -5.15% | 1,082,862 | - |
| 355 | BDTX | Black Diamond Therapeutics, Inc. | 112.88M | -5.74% | 990,395 | 70.00M |
| 356 | PYXS | Pyxis Oncology, Inc. | 112.77M | 4.09% | 844,681 | 13.86M |
| 357 | NTHI | NeOnc Technologies Holdings, Inc. | 111.90M | -3.18% | 52,189 | 39.99K |
| 358 | PLYX | Polaryx Therapeutics, Inc. | 110.31M | -7.91% | 211,920 | - |
| 359 | ENGN | enGene Therapeutics Inc. | 109.86M | -4.65% | 944,992 | - |
| 360 | GUTS | Fractyl Health, Inc. | 107.66M | -7.50% | 2,925,886 | 3.00K |
| 361 | VRCA | Verrica Pharmaceuticals Inc. | 103.76M | -1.79% | 60,525 | 37.16M |
| 362 | COYA | Coya Therapeutics, Inc. | 103.68M | -9.24% | 234,084 | 7.94M |
| 363 | CRDF | Cardiff Oncology, Inc. | 102.55M | -3.23% | 2,816,566 | 525.00K |
| 364 | KLRS | Kalaris Therapeutics, Inc. | 102.09M | -4.72% | 140,295 | - |
| 365 | VANI | Vivani Medical, Inc. | 101.76M | -7.81% | 157,244 | - |
| 366 | SEER | Seer, Inc. | 100.99M | -3.24% | 76,280 | 16.58M |
| 367 | CBUS | Cibus, Inc. | 98.41M | -7.86% | 448,886 | 3.64M |
| 368 | ALDX | Aldeyra Therapeutics, Inc. | 98.32M | -7.39% | 840,598 | - |
| 369 | PEPG | PepGen Inc. | 97.53M | -4.73% | 604,130 | - |
| 370 | ONCY | Oncolytics Biotech Inc. | 97.11M | -3.55% | 1,031,629 | - |
| 371 | CUE | Cue Biopharma, Inc. | 95.90M | -0.61% | 92,215 | 32.73M |
| 372 | OTLK | Outlook Therapeutics, Inc. | 93.87M | -2.28% | 11,768,451 | 333.14K |
| 373 | BMEA | Biomea Fusion, Inc. | 91.82M | -7.30% | 1,351,949 | - |
| 374 | PTHS | Pelthos Therapeutics Inc. | 88.80M | -1.20% | 3,593 | 27.70M |
| 375 | FBIO | Fortress Biotech, Inc. | 88.03M | -4.33% | 326,931 | 66.16M |
| 376 | RNTX | Rein Therapeutics Inc. | 87.75M | -7.54% | 1,096,179 | - |
| 377 | INO | Inovio Pharmaceuticals, Inc. | 87.67M | -7.76% | 3,281,995 | 65.34K |
| 378 | ICCC | ImmuCell Corporation | 86.58M | -3.04% | 11,371 | 29.93M |
| 379 | PYPD | PolyPid Ltd. | 86.28M | -6.83% | 215,055 | - |
| 380 | OKYO | OKYO Pharma Limited | 85.02M | -3.57% | 69,424 | - |
| 381 | ATRA | Atara Biotherapeutics, Inc. | 84.44M | -3.41% | 69,039 | 23.14M |
| 382 | RLYB | Rallybio Corporation | 84.37M | -1.54% | 35,072 | 858.00K |
| 383 | HYFT | MindWalk Holdings Corp. | 83.44M | -9.19% | 557,533 | 20.70M |
| 384 | ANIX | Anixa Biosciences, Inc. | 83.15M | -5.34% | 110,126 | - |
| 385 | RANI | Rani Therapeutics Holdings, Inc. | 82.79M | -7.69% | 838,393 | 3.17M |
| 386 | MAIA | MAIA Biotechnology, Inc. | 82.69M | -9.33% | 1,449,792 | - |
| 387 | PMN | ProMIS Neurosciences, Inc. | 81.88M | -6.17% | 32,373 | - |
| 388 | LIXT | Lixte Biotechnology Holdings, Inc. | 81.33M | - | 149,780 | - |
| 389 | HRTX | Heron Therapeutics, Inc. | 80.90M | -11.60% | 4,276,767 | 150.71M |
| 390 | ANVS | Annovis Bio, Inc. | 80.40M | -5.03% | 1,382,258 | - |
| 391 | AARD | Aardvark Therapeutics, Inc. | 80.28M | -6.60% | 139,871 | - |
| 392 | OSTX | OS Therapies Incorporated | 79.28M | -3.78% | 589,703 | - |
| 393 | EXOZ | eXoZymes, Inc. | 79.19M | -0.11% | 4,691 | -700.00 |
| 394 | NRXS | NeurAxis, Inc. | 78.70M | -5.91% | 141,683 | 4.28M |
| 395 | CSBR | Champions Oncology, Inc. | 78.47M | -1.90% | 726 | 57.95M |
| 396 | LONA | LeonaBio, Inc. | 77.16M | -4.59% | 15,987 | - |
| 397 | ACET | Adicet Bio, Inc. | 76.24M | -10.92% | 86,334 | - |
| 398 | GANX | Gain Therapeutics, Inc. | 72.51M | -8.60% | 616,705 | - |
| 399 | XBIT | XBiotech Inc. | 72.10M | -0.21% | 33,188 | - |
| 400 | PLRX | Pliant Therapeutics, Inc. | 70.59M | -2.56% | 409,103 | - |
| 401 | ATHE | Alterity Therapeutics Limited | 70.35M | - | 11,546 | 4.43M |
| 402 | BYSI | BeyondSpring Inc. | 68.61M | -2.43% | 23,954 | 1.88M |
| 403 | IBIO | iBio, Inc. | 65.78M | -5.70% | 2,285,491 | 300.00K |
| 404 | MNOV | MediciNova, Inc. | 64.48M | -0.76% | 5,394 | 596.64K |
| 405 | MCRB | Seres Therapeutics, Inc. | 64.20M | -3.21% | 280,828 | 1.15M |
| 406 | TCRX | TScan Therapeutics, Inc. | 64.17M | -3.74% | 302,294 | 9.14M |
| 407 | FLNA | Filana Therapeutics, Inc. | 63.77M | -5.71% | 326,027 | - |
| 408 | IMA | ImageneBio, Inc. | 62.94M | -1.93% | 6,564 | 800.00K |
| 409 | ACRV | Acrivon Therapeutics, Inc. | 61.21M | -7.74% | 545,174 | - |
| 410 | IBO | Impact BioMedical Inc. | 61.12M | 0.44% | 66,396 | 39.00K |
| 411 | PMVP | PMV Pharmaceuticals, Inc. | 59.73M | -5.88% | 319,642 | - |
| 412 | CING | Cingulate Inc. | 59.68M | -6.35% | 363,508 | - |
| 413 | INKT | MiNK Therapeutics, Inc. | 59.14M | -6.90% | 51,803 | - |
| 414 | ENTX | Entera Bio Ltd. | 58.09M | -3.28% | 60,295 | 42.00K |
| 415 | PDSB | PDS Biotechnology Corporation | 56.93M | -16.39% | 1,606,497 | - |
| 416 | TIL | Instil Bio, Inc. | 54.73M | -0.86% | 6,307 | - |
| 417 | VERU | Veru Inc. | 54.57M | -19.62% | 10,771,044 | 16.89M |
| 418 | RADX | Radiopharm Theranostics Limited | 50.61M | -6.70% | 30,837 | 10.86M |
| 419 | DWTX | Dogwood Therapeutics, Inc. | 50.44M | -10.12% | 49,918 | - |
| 420 | IMMP | Immutep Limited | 50.02M | -3.09% | 569,183 | 5.28M |
| 421 | MREO | Mereo BioPharma Group plc | 49.99M | -1.51% | 3,541,467 | 500.00K |
| 422 | ESLA | Estrella Immunopharma, Inc. | 48.63M | -1.74% | 6,645 | - |
| 423 | EDSA | Edesa Biotech, Inc. | 48.52M | -22.99% | 764,160 | - |
| 424 | MGX | Metagenomi Therapeutics, Inc. | 48.38M | -3.38% | 274,563 | 22.33M |
| 425 | GNTA | Genenta Science S.p.A. | 48.13M | 4.08% | 741,026 | - |
| 426 | ATYR | aTyr Pharma, Inc. | 46.08M | -8.38% | 2,784,308 | 190.00K |
| 427 | XLO | Xilio Therapeutics, Inc. | 46.07M | -7.34% | 47,833 | 53.48M |
| 428 | LTRN | Lantern Pharma Inc. | 45.80M | -5.28% | 249,428 | - |
| 429 | ACTU | Actuate Therapeutics, Inc. | 44.98M | -3.09% | 63,901 | - |
| 430 | TVGN | Tevogen Bio Holdings Inc. | 43.84M | 6.19% | 100,571 | - |
| 431 | NTRB | Nutriband Inc. | 43.52M | - | 3,823 | 2.04M |
| 432 | HYPD | Hyperion DeFi, Inc. | 42.48M | -14.57% | 791,880 | 1.04M |
| 433 | GRDX | GridAI Technologies Corp. | 42.25M | 4.79% | 121,180 | - |
| 434 | TELO | Telomir Pharmaceuticals, Inc. | 41.60M | -4.72% | 73,242 | - |
| 435 | GOSS | Gossamer Bio, Inc. | 41.07M | -1.57% | 9,951,020 | 55.54M |
| 436 | RNXT | RenovoRx, Inc. | 39.29M | -10.60% | 325,795 | 1.49M |
| 437 | ATOS | Atossa Therapeutics, Inc. | 38.49M | -7.84% | 80,839 | - |
| 438 | KALA | KALA BIO, Inc. | 38.30M | -7.62% | 123,063 | - |
| 439 | PSTV | Plus Therapeutics, Inc. | 37.12M | -5.83% | 120,129 | 5.21M |
| 440 | GRCE | Grace Therapeutics, Inc. | 35.59M | -3.77% | 286,083 | - |
| 441 | ATNM | Actinium Pharmaceuticals, Inc. | 33.67M | -2.70% | 197,094 | 90.00K |
| 442 | ABVC | ABVC BioPharma, Inc. | 33.61M | -7.64% | 180,196 | 797.92K |
| 443 | INMB | INmune Bio Inc. | 33.50M | -6.67% | 327,665 | 50.00K |
| 444 | BOLD | Boundless Bio, Inc. | 31.83M | -3.40% | 60,181 | - |
| 445 | NNVC | NanoViricides, Inc. | 31.44M | -8.00% | 665,110 | - |
| 446 | APLM | Apollomics, Inc. | 30.74M | - | 19,054 | 8.84M |
| 447 | ALGS | Aligos Therapeutics, Inc. | 30.38M | -8.05% | 127,919 | 4.71M |
| 448 | LSTA | Lisata Therapeutics, Inc. | 30.26M | -0.59% | 22,732 | 170.00K |
| 449 | SNTI | Senti Biosciences Holdings, Inc. | 30.07M | -3.46% | 225,576 | 38.00K |
| 450 | EVAX | Evaxion A/S | 29.61M | -8.27% | 57,640 | 7.53M |
| 451 | QNTM | Quantum BioPharma Ltd. | 28.72M | -4.91% | 382,592 | - |
| 452 | IGC | IGC Pharma, Inc. | 28.26M | -2.29% | 434,830 | 1.11M |
| 453 | DARE | Daré Bioscience, Inc. | 28.16M | -13.76% | 448,316 | 1.16M |
| 454 | BCTX | BriaCell Therapeutics Corp. | 28.10M | -5.52% | 178,194 | - |
| 455 | SER | Serina Therapeutics, Inc. | 28.01M | 1.08% | 144,087 | 130.00K |
| 456 | CRVO | CervoMed Inc. | 27.22M | -5.77% | 62,169 | 2.09M |
| 457 | TVRD | Tvardi Therapeutics, Inc. | 27.11M | -6.17% | 80,964 | - |
| 458 | KYNB | Kyntra Bio, Inc. | 27.04M | -1.91% | 6,834 | 7.44M |
| 459 | BRNS | Barinthus Biotherapeutics plc | 26.64M | -6.95% | 3,212 | 14.97M |
| 460 | NRSN | NeuroSense Therapeutics Ltd. | 26.52M | -3.85% | 102,135 | - |
| 461 | DYAI | Dyadic International, Inc. | 25.87M | -1.85% | 75,827 | 3.81M |
| 462 | SKYE | Skye Bioscience, Inc. | 25.76M | -5.37% | 168,256 | - |
| 463 | LITS | Lite Strategy, Inc. | 25.48M | -13.35% | 778,720 | - |
| 464 | PLUR | Pluri Inc. | 25.46M | -0.84% | 7,126 | 1.08M |
| 465 | CELU | Celularity Inc. | 25.25M | -12.33% | 34,202 | 26.55M |
| 466 | ALLR | Allarity Therapeutics, Inc. | 24.89M | -5.29% | 156,939 | 345.00K |
| 467 | PLRZ | Polyrizon Ltd. | 24.32M | 1.48% | 48,176 | - |
| 468 | NEUP | Neuphoria Therapeutics Inc. | 24.27M | -7.23% | 82,566 | -13.27K |
| 469 | PTN | Palatin Technologies, Inc. | 24.16M | -1.32% | 7,921 | 12.88M |
| 470 | MRKR | Marker Therapeutics, Inc. | 23.68M | -3.40% | 50,241 | 3.55M |
| 471 | VYNE | VYNE Therapeutics Inc. | 21.86M | -1.35% | 50,970 | 454.00K |
| 472 | VTGN | Vistagen Therapeutics, Inc. | 21.55M | -5.51% | 494,836 | 789.00K |
| 473 | LGVN | Longeveron Inc. | 21.38M | -8.75% | 306,047 | 1.22M |
| 474 | TRAW | Traws Pharma, Inc. | 20.76M | -7.43% | 354,461 | 2.73M |
| 475 | CLRB | Cellectar Biosciences, Inc. | 20.70M | -5.82% | 183,607 | - |
| 476 | CVM | CEL-SCI Corporation | 19.86M | -10.46% | 336,922 | - |
| 477 | SNSE | Sensei Biotherapeutics, Inc. | 19.66M | -11.75% | 50,831 | - |
| 478 | KTTA | Pasithea Therapeutics Corp. | 19.55M | -5.63% | 389,908 | - |
| 479 | HOWL | Werewolf Therapeutics, Inc. | 19.06M | -8.77% | 580,539 | 1.14M |
| 480 | AEON | AEON Biopharma, Inc. | 18.99M | -2.12% | 18,233 | - |
| 481 | CRIS | Curis, Inc. | 18.92M | -5.34% | 340,477 | 7.06M |
| 482 | XCUR | Exicure, Inc. | 18.61M | -1.35% | 17,186 | 500.00K |
| 483 | TPST | Tempest Therapeutics, Inc. | 18.22M | -2.31% | 105,260 | - |
| 484 | PASG | Passage Bio, Inc. | 18.03M | -6.33% | 34,781 | - |
| 485 | AKTX | Akari Therapeutics, Plc | 17.25M | -4.86% | 60,054 | - |
| 486 | CALC | CalciMedica, Inc. | 16.69M | 24.62% | 2,806,682 | - |
| 487 | QNCX | Quince Therapeutics, Inc. | 16.46M | -8.18% | 797,037 | - |
| 488 | LPCN | Lipocine Inc. | 16.45M | -7.24% | 76,975 | 2.00M |
| 489 | LEXX | Lexaria Bioscience Corp. | 15.79M | 0.16% | 51,451 | 368.00K |
| 490 | NCEL | NewcelX Ltd. | 15.77M | -6.98% | 17,125 | - |
| 491 | GTBP | GT Biopharma, Inc. | 15.74M | -8.51% | 1,304,433 | - |
| 492 | MLEC | Moolec Science SA | 15.54M | -7.09% | 23,311 | 7.83M |
| 493 | CTXR | Citius Pharmaceuticals, Inc. | 15.37M | -5.00% | 261,810 | 5.61M |
| 494 | GDTC | CytoMed Therapeutics Limited | 15.26M | 9.32% | 13,875 | 669.28K |
| 495 | HIND | Vyome Holdings, Inc. | 15.16M | -6.09% | 14,256 | 152.72K |
| 496 | BLRX | BioLineRx Ltd. | 14.51M | -3.87% | 6,704 | 1.40M |
| 497 | INAB | IN8bio, Inc. | 14.28M | -5.84% | 71,469 | - |
| 498 | JSPR | Jasper Therapeutics, Inc. | 13.79M | 2.37% | 548,465 | - |
| 499 | CVKD | Cadrenal Therapeutics, Inc. | 13.67M | 3.02% | 58,924 | - |
| 500 | OSRH | OSR Holdings, Inc. | 13.62M | -6.73% | 931,370 | 2.63M |